Vanderbilt University Medical Center researchers have developed two innovative AI technologies to improve cancer care. The first, MSI-SEER, predicts microsatellite instability-high status from pathology slides, potentially identifying more patients who could benefit from immunotherapy. The second is a 3D imaging tool that provides detailed tissue analysis at the subcellular level. These advancements demonstrate how VUMC is using AI to address various medical needs. The 3D imaging technology has applications beyond cancer diagnostics, including drug development and organ transplant assessment.